Elk Run BioBusiness Park
-
From rural Elk Run to Third World Chile, Burrill searches for capital
Steve Burrill may have encountered some difficulty raising local money for a planned $1 billion […]
-
Elk Run project taps real estate giant to market property
Backers of the Elk Run BioBusiness Park in Pine Island, Minnesota have hired the Minneapolis […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Could Minnesota’s budget fiasco derail angel credit, economic development?
Not to sound paranoid … but … Just when you think Minnesota has turned the […]
-
BIO 2010: Minnesota faces crossroads in its high-tech future
To BIO or not to BIO? That’s the question confronting Minnesota as it ponders its […]
-
Minnesota guv candidates try to woo biotech crowd (with, um, mixed results)
It’s always a tough act to follow Howard Root, the sometimes volatile, always interesting CEO […]
-
Gambling money to fund Elk Run bioscience project?
Forget the elk. Bring on the horses! The proposed Elk Run BioBusiness Park in Pine […]
-
Upwind Medical Partners to create $8 million early stage fund
Another day, another new local early stage fund. Upwind Medical Partners is launching a $6 […]
-
Night Read (Minnesota): Bad economy forces Elk Run developer to alter biotech plans
Ground was supposed to have been broken in the fourth quarter of 2008, according to Tower Investments. Now, after delays and increasing skepticism from the public, John Pierce, senior vice president at Tower Investments LLC, said that plans have changed.
-
Affinity Capital and Triathlon Medical Ventures plan new $10M early stage fund in Minnesota
Affinity’s fund is not tied to a specific incubator, which means the firm will cast a larger net for start-ups. Given its history of investing exclusively in late stage companies, Affinity’s move could provide Minnesota’s early stage entrepreneurs a real shot in the arm.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Night Read (Minnesota): Burrill bets $8 million on St. Paul biopharm start-up
In a speech at the annual meeting of the Rochester Economic Development Corp., Burrill was still short on details on the Elk Run BioBusiness Park in Pine Island.
-
Night Read (Minnesota): Family loses appeal for third trial in Mayo malpractice case
The Becker’s attorney, Chris Messerly of Minneapolis, moved for a new trial last year after an Olmsted County jury found no negligence on the part of Mayo Clinic doctors in treatment Nykkole when she was just weeks old.
-
University of Minnesota and developers plan $20M venture fund to anchor major science park
The park should be Minnesota’s answer to Research Triangle Park in North Carolina, a place where academics, scientists, investors and entrepreneurs converge to create breakthrough innovations developed and sold by homegrown companies, said Peter Bianco, director of lifescience business development of Halleland Health Consulting in Minneapolis. Bianco is spearheading the project.
-
Can Miromatrix “regenerate” Minnesota’s medical industry? An exclusive interview with Dr. Doris Taylor and Miromatrix CEO Rob Cohen
Miromatrix is close to signing a licensing agreement with the University of Minnesota to commercialize the regenerative tissue work of Dr. Doris Taylor. Two years ago, the star university scientist drew international attention for successfully growing — and keeping alive — a beating rat’s heart in a jar. Taylor’s work fueled hopes that scientists can one day grow replacement organs for patients who would typically wait for transplants.
-
Night Read (Minnesota): Pine Island approves financing plan for Elk Run bioscience project; University of Minnesota president has cancer
The Pine Island city council voted to create a nearly $3 million infrastructure financing plan for the Elk Run biotechnology project while University of Minnesota president Robert Bruininks discloses he has prostate cancer.
-
New Minnesota biotech fund seeks $25 million with a little help from Steve Burrill and yours truly
Burrill is having trouble finding local money for the $500 million of the Elk Run fund that will purchase direct equity stakes in start-ups housed at the planned Elk Run Biosciences Center. So it’s no surprise that Coordinate is trying to appeal to the state’s sense of economic pride.